Moreover, serum soluble interleukin-2 receptor (sIL-2R), serum lactic dehydrogenase (LDH), and C-reactive protein (CRP) have been recently used as markers of tumor burden and disease activity in ML. The gene discussed is CRP; the disease is neoplasm.